126 related articles for article (PubMed ID: 32686008)
21. Folding of the polyketide chain is not dictated by minimal polyketide synthase in the biosynthesis of mithramycin and anthracycline.
Kantola J; Blanco G; Hautala A; Kunnari T; Hakala J; Mendez C; Ylihonko K; Mäntsälä P; Salas J
Chem Biol; 1997 Oct; 4(10):751-5. PubMed ID: 9375253
[TBL] [Abstract][Full Text] [Related]
22. Mithramycin delivery systems to develop effective therapies in sarcomas.
Estupiñán Ó; Niza E; Bravo I; Rey V; Tornín J; Gallego B; Clemente-Casares P; Moris F; Ocaña A; Blanco-Lorenzo V; Rodríguez-Santamaría M; Vallina-Álvarez A; González MV; Rodríguez A; Hermida-Merino D; Alonso-Moreno C; Rodríguez R
J Nanobiotechnology; 2021 Sep; 19(1):267. PubMed ID: 34488783
[TBL] [Abstract][Full Text] [Related]
23. Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins.
Hou C; Mandal A; Rohr J; Tsodikov OV
Structure; 2021 May; 29(5):404-412.e4. PubMed ID: 33275876
[TBL] [Abstract][Full Text] [Related]
24. Engineering of Streptomyces lividans for heterologous expression of secondary metabolite gene clusters.
Ahmed Y; Rebets Y; Estévez MR; Zapp J; Myronovskyi M; Luzhetskyy A
Microb Cell Fact; 2020 Jan; 19(1):5. PubMed ID: 31918711
[TBL] [Abstract][Full Text] [Related]
25. Analysis of two chromosomal regions adjacent to genes for a type II polyketide synthase involved in the biosynthesis of the antitumor polyketide mithramycin in Streptomyces argillaceus.
Prado L; Lombó F; Braña AF; Méndez C; Rohr J; Salas JA
Mol Gen Genet; 1999 Mar; 261(2):216-25. PubMed ID: 10102355
[TBL] [Abstract][Full Text] [Related]
26. Mithramycin represses MDR1 gene expression in vitro, modulating multidrug resistance.
Tagashira M; Kitagawa T; Isonishi S; Okamoto A; Ochiai K; Ohtake Y
Biol Pharm Bull; 2000 Aug; 23(8):926-9. PubMed ID: 10963297
[TBL] [Abstract][Full Text] [Related]
27. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
[TBL] [Abstract][Full Text] [Related]
28. Construction of the co-expression plasmids of fostriecin polyketide synthases and heterologous expression in Streptomyces.
Su C; Zhao X; Qiu R; Tang L
Pharm Biol; 2015 Feb; 53(2):269-74. PubMed ID: 25427408
[TBL] [Abstract][Full Text] [Related]
29. How mithramycin stereochemistry dictates its structure and DNA binding function.
Hou C; Rohr J; Parkin S; Tsodikov OV
Medchemcomm; 2019 May; 10(5):735-741. PubMed ID: 31191864
[TBL] [Abstract][Full Text] [Related]
30. Rational construction of genome-reduced and high-efficient industrial Streptomyces chassis based on multiple comparative genomic approaches.
Bu QT; Yu P; Wang J; Li ZY; Chen XA; Mao XM; Li YQ
Microb Cell Fact; 2019 Jan; 18(1):16. PubMed ID: 30691531
[TBL] [Abstract][Full Text] [Related]
31. Insertional inactivation of mtrX and mtrY genes from the mithramycin gene cluster affects production and growth of the producer organism Streptomyces argillaceus.
Garcia-Bernardo J; Braña AF; Méndez C; Salas JA
FEMS Microbiol Lett; 2000 May; 186(1):61-5. PubMed ID: 10779713
[TBL] [Abstract][Full Text] [Related]
32. Bioanalytical method for quantitative determination of mithramycin analogs in mouse plasma by HPLC-QTOF.
Eckenrode JM; Mitra P; Rohr J; Leggas M
Biomed Chromatogr; 2019 Aug; 33(8):e4544. PubMed ID: 30927450
[TBL] [Abstract][Full Text] [Related]
33. Mithramycin and its analogs: Molecular features and antitumor action.
Portugal J
Pharmacol Ther; 2024 Jun; 260():108672. PubMed ID: 38838821
[TBL] [Abstract][Full Text] [Related]
34. [High Expression Level of SP1, CSF1R, and PAK1 Correlates with Sensitivity of Leukemia Cells to the Antibiotic Mithramycin].
Vagapova ER; Lebedev TD; Tikhonova AD; Goikhman BV; Ivanenko KA; Spirin PV; Prassolov VS
Mol Biol (Mosk); 2020; 54(3):522-528. PubMed ID: 32492016
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional regulation of mithramycin biosynthesis in Streptomyces argillaceus: dual role as activator and repressor of the PadR-like regulator MtrY.
Flórez AB; Álvarez S; Zabala D; Braña AF; Salas JA; Méndez C
Microbiology (Reading); 2015 Feb; 161(Pt 2):272-284. PubMed ID: 25416691
[TBL] [Abstract][Full Text] [Related]
36. Engineered
Peng Q; Gao G; Lü J; Long Q; Chen X; Zhang F; Xu M; Liu K; Wang Y; Deng Z; Li Z; Tao M
Front Microbiol; 2018; 9():3042. PubMed ID: 30619133
[No Abstract] [Full Text] [Related]
37. Deciphering the biosynthetic origin of the aglycone of the aureolic acid group of anti-tumor agents.
Blanco G; Fu H; Mendez C; Khosla C; Salas JA
Chem Biol; 1996 Mar; 3(3):193-6. PubMed ID: 8807845
[TBL] [Abstract][Full Text] [Related]
38. Semi-synthetic mithramycin SA derivatives with improved anticancer activity.
Scott D; Chen JM; Bae Y; Rohr J
Chem Biol Drug Des; 2013 May; 81(5):615-24. PubMed ID: 23331575
[TBL] [Abstract][Full Text] [Related]
39. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
[TBL] [Abstract][Full Text] [Related]
40. Oxidative cleavage of premithramycin B is one of the last steps in the biosynthesis of the antitumor drug mithramycin.
Prado L; Fernández E; Weissbach U; Blanco G; Quirós LM; Braña AF; Méndez C; Rohr J; Salas JA
Chem Biol; 1999 Jan; 6(1):19-30. PubMed ID: 9889148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
